Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles Published September 2019 Citation Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC. . World Conference on Lung Cancer. . Authors:Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet need More publicationsESMO Real World Data and Digital OncologyJuly 2026A scoping review of real-world data sources for retrospective oncology analysis in JapanNg D, Pittell H, Nasu I, et al.Publication summaryPublicationsASCO Annual MeetingMay 2026Real-world biomarker testing rates, targeted therapy use, and clinical outcomes in patients with advanced gastric or GEJ cancer in the United StatesDamato L, Liao NS, Bryan J, Hankinson EA, Castellanos E.Publication summaryPublicationsPrecision medicineGastric/Esophageal cancerASCO Annual MeetingMay 2026From plenary to practice: A large language model (LLM)-based thematic analysis of landmark clinical trial discussions and factors influencing their real-world adoptionCohen AB, Williams T, Aggarwal C, et al.Publication summaryPublicationsMachine learningArtificial intelligence